Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis

Marcelo F. Jimenez*, Angela van Baardwijk, Hugo J. W. L. Aerts, Dirk De Ruysscher, Nuria M. Novoa, Gonzalo Varela, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
3 Downloads (Pure)
Original languageEnglish
Pages (from-to)413-417
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - Dec 2010


  • Non-small cell lung cancer
  • Lung resection
  • High-dose radiotherapy
  • Propensity scoring analysis

Cite this